# The analysis includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters.

*biotech · news · 2026-05-06 · Fortune*

## Key points

- White House analysis estimates $733 billion in potential prescription drug savings over a decade.
- Few details of Trump's deals with 17 major pharmaceutical companies have been publicly disclosed.
- Democrats argue the savings could be offset by higher costs for drugs not covered by the policy.
- Sen. Sanders’ staff analysis found drug company profits rose 66% since agreeing to Trump's plan.
- Trump administration claims projected savings are based on actual patient prices, not list prices.

**Countries:** United States, Iran

[Read the full story on Fortune](https://fortune.com/2026/05/06/that-alone-should-win-us-the-midterms-trump-wants-voters-to-ignore-higher-costs-giant-pharma-profits-and-focus-on-drug-prices/)

---

Canonical: https://newsio.io/n/f49008e8-708a-4ae4-955a-ce93143677f8/the-analysis-includes-the-first-economy-wide-projections-behind-a-policy-at-the
Summarized by Newsio from Fortune. https://newsio.io/how-it-works